Docquity Drives Demand for SIT Pharma’s Duo Probiotics in Thailand, Achieving 31% Sales Growth in 6 months
Docquity’s Awareness to Advocacy (A2A) Program and strong local distribution network enabled SIT’s duo probiotic sales to surpass the market growth rate of 15%The technology platform boosted SIT’s HCP education efforts, more than doubling its reach to 2,000 HCPs within six months
Docquity Drives Demand for SIT Pharma’s Duo Probiotics in Thailand, Achieving 31% Sales Growth in 6 months
Docquity’s Awareness to Advocacy (A2A) Program and strong local distribution network enabled SIT’s duo probiotic sales to surpass the market growth rate of 15%The technology platform boosted SIT’s HCP education efforts, more than doubling its reach to 2,000 HCPs within six months
Tonik Bank is now in Cebu!
CEBU CITY, Philippines, Aug. 7, 2024 /PRNewswire/ — Hello, langga! #VivaTonikBank The Philippines’ trailblazing digital bank, Tonik, announces its expansion to Cebu, bringing its full suite of customer-centric and innovative products to this vibrant region. This move underscores Tonik
Tonik Bank is now in Cebu!
CEBU CITY, Philippines, Aug. 7, 2024 /PRNewswire/ — Hello, langga! #VivaTonikBank The Philippines’ trailblazing digital bank, Tonik, announces its expansion to Cebu, bringing its full suite of customer-centric and innovative products to this vibrant region. This move underscores Tonik
Manas Pathak, CEO of EarthEn Energy, recognized in Marquis Who’s Who in America for Pioneering Efforts in Combating Climate Change
PHOENIX, Aug. 6, 2024 /PRNewswire/ — EarthEn Energy is proud to announce that its CEO, Manas Pathak, has been included in the 2024-2025 Marquis Who’s Who in America for his outstanding contributions to addressing climate change. Marquis Who’s Who is a prestigious publication that
Senhwa Biosciences receives US FDA Study May Proceed letter for the Phase I/II study of Silmitasertib (CX-4945) in combination with chemotherapy in children and young adults with relapsed refractory solid tumors
TAIPEI and SAN DIEGO, Aug. 6, 2024 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced receipt of a “Study May Proceed” letter from the U.S. F
Cloudera Strengthens Metadata Management with Modernized Data Catalog and Iceberg REST Integration
Cloudera’s latest updates enhance open interoperability while addressing growing demands for data security and governance Platform updates will be on display during EVOLVE24 in Singapore August 6-7 SANTA CLARA, Calif., Aug. 7, 2024 /PRNewswire/ — Cloudera, the only true hybrid platform
ADP Expands ADP SecurTime to the Philippines
MANILA, Philippines, Aug. 7, 2024 /PRNewswire/ — ADP, a global leader in payroll and human capital management solutions, announces the rollout of ADP SecurTime, its cloud-based time and attendance solution, in the Philippines. This rollout aims to streamline payroll and workforce management p
GSK’s Jemperli (dostarlimab) plus chemotherapy approved in Singapore as the first frontline immuno-oncology treatment for dMMR/MSI-H primary advanced or recurrent endometrial cancer
Jemperli in combination with chemotherapy is the first immuno-oncology treatment approved in the frontline setting for this patient population in Singapore.[1,2]Latest published local registry reported endometrial cancer as the fourth most common cancer and had the ninth highest cancer mortality rat
L Catterton Makes Strategic Investment in Viee
Partnership leveraging L Catterton’s operating know-how will help entrench Viee’s leading position in Sichuan and Chongqing and facilitate expansion in nearby provinces CHENGDU, China, Aug. 6, 2024 /PRNewswire/ — L Catterton, a leading global consumer-focused investment firm, tod
